Patient Reported Scale vs CTCAE Grading: A Prospective Comparator Study
Condition(s):Gastrointestinal CancerLast Updated:April 19, 2023Suspended
Hide Studies Not Open or Pending
Condition(s):Gastrointestinal CancerLast Updated:April 19, 2023Suspended
Condition(s):All CancerLast Updated:December 17, 2021Completed
Condition(s):Breast Cancer FemaleLast Updated:December 22, 2023Recruiting
Condition(s):Breast Cancer; Advanced Breast Cancer; Metastatic Breast CancerLast Updated:December 22, 2023Completed
Condition(s):Ovarian CancerLast Updated:January 31, 2020Completed
Condition(s):Adenocarcinoma of ProstateLast Updated:December 22, 2023Completed
Condition(s):Carcinoma Breast Stage IVLast Updated:December 17, 2021Completed
Condition(s):Malignant Neoplasm of Oropharynx Stage III; Malignant Neoplasm of Larynx Stage III; Malignant Neoplasm of Hypopharynx Stage III; Malignant Neoplasm of Oropharynx Stage IVa; Malignant Neoplasm of Oropharynx Stage IVb; Malignant Neoplasm of Larynx Stage IV; Malignant Neoplasm of Hypopharynx Stage IVa; Malignant Neoplasm of Hypopharynx Stage IVbLast Updated:December 28, 2023Completed
Condition(s):Prostate AdenocarcinomaLast Updated:April 1, 2021Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.